Diuretic effect of NG-nitro-L-arginine methyl ester in the rat

Sensitivity of USPIO-enhanced R2 imaging to dynamic blood volume changes in the rat kidney

PURPOSE

To determine whether MRI in combination with an intravascular contrast agent is sensitive to pharmacologically induced vasodilation and vasoconstriction in the rat kidney.

MATERIALS AND METHODS

R(2) imaging was performed in 25 Sprague Dawley rats at 3 Tesla in the presence of ferumoxytol, an ultrasmall superparamagnetic iron oxide (USPIO) agent with a long plasma half-life. R(2) changes were measured following manipulation of blood volume by intravenous administration of adenosine, a short-acting vasodilator, or N(G)-nitro-L-arginine methyl ester (L-NAME), a long-acting nitric oxide synthase inhibitor with known vasoconstrictive effects. As a control, R(2) responses to adenosine and L-NAME were also examined in the absence of ferumoxytol.

RESULTS

In the presence of ferumoxytol, adenosine induced a significant increase in R(2), while L-NAME produced a reduction, although the latter was not statistically significant. Control experiments revealed small R(2) changes in the absence of ferumoxytol. An incidental finding was that the cross-sectional area of the kidney also varied dynamically with adenosine and L-NAME.

CONCLUSION

Our results suggest that ferumoxytol-enhanced R(2) imaging is sensitive to adenosine-induced vasodilation. The responses to L-NAME, however, were not statistically significant. The variations in kidney size and the R(2) changes in the absence of ferumoxytol may reflect alterations in the volume of the renal tubules.

Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells

In collecting duct principal cells, aquaporin 2 (AQP2) is shuttled from intracellular vesicles to the plasma membrane upon vasopressin (VP) stimulation. VP activates adenylyl cyclase, increases intracellular cAMP, activating protein kinase A (PKA) to phosphorylate AQP2 on the COOH-terminal residue, serine 256. Using rat kidney slices and LLC-PK1 cells stably expressing AQP2 (LLC-AQP2 cells), we now show that AQP2 trafficking can be stimulated by cAMP-independent pathways. In these systems, the nitric oxide (NO) donors sodium nitroprusside (SNP) and NONOate and the NO synthase substrate L-arginine mimicked the effect of VP, stimulating relocation of AQP2 from cytoplasmic vesicles to the plasma membrane. Unlike VP, these other agents did not increase intracellular cAMP. However, SNP increased intracellular cGMP, and exogenous cGMP stimulated AQP2-membrane insertion. Atrial natriuretic factor, which signals via cGMP, also stimulated AQP2 translocation. The VP and SNP effects were blocked by the kinase inhibitor H89. SNP did not stimulate membrane insertion of AQP2 in LLC-PK1 cells expressing the phosphorylation-deficient mutant 256SerAla-AQP2, indicating that phosphorylation of Ser256 is required for signaling. Both PKA and cGMP-dependent protein kinase G phosphorylated AQP2 on this COOH-terminal residue in vitro. These results demonstrate a novel, cAMP-independent and cGMP-dependent pathway for AQP2 membrane insertion in renal epithelial cells.